Connect Biopharma Holdings (CNTB) Assets Average (2021 - 2026)

Connect Biopharma Holdings has disclosed Assets Average across 5 years of filings, most recently posting $51.8 million for Q2 2026.

• In Q2 2026, Assets Average fell 40.97% year-over-year to $51.8 million; the TTM figure through Jun 2026 stood at $51.8 million (down 40.97% YoY), while the FY2025 annual figure was $78.7 million, down 31.18% from the prior year.
• Assets Average came in at $51.8 million for Q2 2026 at Connect Biopharma Holdings, down from $58.1 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $262.5 million in Q2 2022 to a low of $51.8 million in Q2 2026.
• Average Assets Average over 4 years is $118.9 million, with a median of $92.3 million recorded in 2025.
• Year-over-year, Assets Average slipped 10.76% in 2022 and sank 40.97% in 2026.
• Over 4 years, Assets Average stood at $202.5 million in 2022, then sank by 32.99% to $135.7 million in 2023, then slumped by 54.53% to $61.7 million in 2025, then dropped by 16.12% to $51.8 million in 2026.
• Per Business Quant data, the three most recent Assets Average figures were $51.8 million in Q2 2026, $58.1 million in Q1 2026, and $61.7 million in Q4 2025.